SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-024249
Filing Date
2023-05-25
Accepted
2023-05-25 16:19:01
Documents
14
Period of Report
2023-05-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K labp-20230523.htm   iXBRL 8-K 120326
2 EX-3.1 labp-ex3_1.htm EX-3.1 18534
3 EX-99.1 labp-ex99_1.htm EX-99.1 14782
  Complete submission text file 0000950170-23-024249.txt   287315

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT labp-20230523.xsd EX-101.SCH 2483
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT labp-20230523_pre.xml EX-101.PRE 11443
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT labp-20230523_lab.xml EX-101.LAB 13895
8 EXTRACTED XBRL INSTANCE DOCUMENT labp-20230523_htm.xml XML 4875
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39971 | Film No.: 23960821
SIC: 2834 Pharmaceutical Preparations